Price & Technical Structure
- Short-term returns show a mixed picture with a 1.44% gain in the last day but a significant -27.62% decline over the past three months.
- The trend regime is bearish, indicated by a negative trend alignment score of -3 and the price being 8.15% below its 50-day moving average and 18.58% below its 200-day moving average.
- Momentum is weak, with an RSI of 38.75, suggesting oversold conditions, and a bearish MACD signal.
- Volatility is moderate, with the price trading at 30.46% of the Bollinger Band width, and an annualized volatility of 33.02%.
- The stock is positioned structurally 30.17% below its 52-week high and 2.42% above its 52-week low, with a current drawdown of -30.17%. The average 20-day delivery is 49.68% with accumulation signs.
The market behaviour indicates a predominantly bearish trend, characterized by negative price action relative to key moving averages and a bearish MACD signal. While short-term returns have been volatile, the longer-term trend and momentum indicators suggest a period of weakness. The stock is trading significantly below its 52-week high, but shows some resilience above its 52-week low. Moderate volatility and signs of accumulation in delivery volume warrant attention, but the overall technical picture remains bearish.
Weekly Momentum
- The stock hit a 52-week low of 12.17 USD on May 6, 2026, following the completion of the Optimum Healthcare IT acquisition.
- Technical momentum remains bearish as the price continues to trade significantly below its 50-day and 200-day moving averages.
- The Relative Strength Index (RSI), a measure of momentum indicating if an asset is overbought or oversold, sits at 38.75, reflecting a bearish zone.
- Financial results for the quarter ending March 2026 show a 20.9% year-over-year increase in net profit, despite recent market concerns regarding future growth.
- Management has initiated a series of investor meetings and roadshows across North America and Asia to engage with institutional stakeholders.
Infosys is currently navigating a period of downward price pressure, evidenced by the stock reaching a 52-week low this week. While the company reported strong quarterly growth with a 20.9% year-over-year increase in net profit, market sentiment remains cautious, reflected in analyst downgrades and concerns over future growth rates. The technical profile is firmly bearish, with the price trading well below long-term moving averages and momentum indicators like the RSI remaining in a weak zone. The company is actively working to address investor sentiment through a series of global roadshows and conferences following the recent acquisition of Optimum Healthcare IT.
Quarterly Analysis
Net Profit rose to ₹8,509 Cr (+20.9% YoY), indicating strong profitability growth driven by significant increases in other comprehensive income.
Revenue increased to ₹46,402 Cr (+13.4% YoY), demonstrating robust top-line expansion compared to the previous year.
Employee Benefit Expense increased to ₹24,688 Cr (+12.1% YoY), reflecting higher costs associated with personnel.
Tax Expense decreased to ₹2,288 Cr (-12.8% YoY), which positively impacted net profit.
Other Comprehensive Income Net Of Taxes surged to ₹1,055 Cr (+284.0% YoY), significantly contributing to overall income.
The quarter's performance was characterized by strong revenue growth and a significant increase in net profit, largely driven by a substantial rise in Other Comprehensive Income. While operating expenses like employee benefits increased, a decrease in tax expenses contributed positively to the overall profit picture.
Infosys delivered a strong financial performance in the fourth quarter of FY26, marked by substantial year-over-year growth in both revenue and net profit. Revenue reached ₹46,402 Cr, an increase of 13.4% compared to the same quarter last year. This top-line growth indicates a healthy expansion of the company's business.
Profitability saw a significant boost, with Net Profit rising to ₹8,509 Cr, a 20.9% increase year-over-year. This improvement was notably supported by a substantial surge in Other Comprehensive Income Net Of Taxes, which increased by 284.0% to ₹1,055 Cr. This exceptional item played a key role in enhancing the company's overall income for the period.
While revenue and net profit grew, the company also experienced an increase in expenses. Employee Benefit Expense rose by 12.1% year-over-year to ₹24,688 Cr. However, Tax Expense decreased by 12.8% to ₹2,288 Cr compared to the same quarter last year, which provided a positive offset to rising costs.